Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

2
results for

"Masaaki Mino"

Article category

Keywords

Publication year

"Masaaki Mino"

Correspondence

Citations

Citations to this article as recorded by  Crossref logo
  • Metabolic and genetic mechanisms of metabolic dysfunction-associated steatotic liver disease: an integrative perspective from molecular pathways to clinical challenges
    Jingyuan Ma, Yanna Ma, Xing Wan, Junchen Li, Yunshu Zhang, Jifeng Liu, Yunhai Gao
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • 4,022 View
  • 30 Download
  • Crossref
Review
Metabolic dysfunction-associated steatotic liver disease (MASLD) and its relatively advanced form, metabolic dysfunction-associated steatohepatitis (MASH), are becoming increasingly prevalent worldwide, making their prevention and management an urgent global health priority. Central to their development are key metabolic defects, including abnormal concentrations of monosaccharides, fatty acids, and amino acids, but the complex relationships between these substances within the hepatic microenvironment remain only partially understood. Dysregulated glucose metabolism and selective insulin resistance (IR) promote hepatic gluconeogenesis, glycolysis, and de novo lipogenesis; and excessive concentrations of free fatty acids from the diet and adipose tissue drive steatosis. Emerging evidence also implies that amino acid metabolism affects mitochondrial function and redox balance. Dysfunctional mitochondrial oxidative phosphorylation and the associated increase in reactive oxygen species production further exacerbate the cellular stress, inflammation, and fibrosis. However, compared with monosaccharide and fatty acid metabolism, the role of amino acid metabolism in MASLD/MASH remains less well understood. A better understanding of the role of such metabolic dysfunction in liver pathobiology should aid the identification of more useful biomarkers and precision therapies for MASLD/MASH.

Citations

Citations to this article as recorded by  Crossref logo
  • Precision medicine in steatotic liver disease
    Vitchapong Prasitsumrit, Vincent L. Chen
    Current Opinion in Gastroenterology.2026; 42(3): 121.     CrossRef
  • Immunometabolism of IRF4 in adipose, muscle, and immune cells influences obesity and MASLD
    Daniel M. Marko, Jonathan D. Schertzer
    American Journal of Physiology-Endocrinology and Metabolism.2026; 330(4): E520.     CrossRef
  • Colorimetric detection of amino acids enabled by functional nanomaterials: mechanisms, performance evaluation, and translational perspectives
    Wenfeng Ren, Wenyu Tu, Jiqiang Guo, Ying Gao
    Microchimica Acta.2026;[Epub]     CrossRef
  • Letter to the editor on “Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunctionassociated steatotic liver disease”
    Xinyi Cai, Lu Zhang, Tuo Li
    Clinical and Molecular Hepatology.2026; 32(2): e136.     CrossRef
  • Metabolic features in plasma and urine of obese children and their association with MAFLD risk
    Shuang Hu, Wu Yan, Su Wu, Qianqi Liu, Xiaonan Li
    Frontiers in Nutrition.2026;[Epub]     CrossRef
  • Correspondence to letter to the editor on “Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunctionassociated steatotic liver disease”
    Eiji Kakazu, Masaaki Mino, Tatsuya Kanto
    Clinical and Molecular Hepatology.2026; 32(2): e235.     CrossRef
  • Blood Focused-Metabolomics and Transcriptomics Uncover Non-Linear Risk Association of Inadequate Dietary Choline Intake-Linked Metabolic Stress with MASLD Through Amino Acid Biomarkers, BCAA and MTORC 1/AKT1/IRS1 Mechanistic Mediators: A Nested Case–Contr
    Chien-Hsien Wu, Ming-Lu Lin, Chao-Yun Wang, Chi-Yang Chang, Fu-Jen Lee, Mei-Ling Cheng, Yu-Shun Lin, Tong-Wei Chen, Yi-Ting Hsiao, Bei-Wen Wang, Chang-Sheng Kuo, Rwei-Fen S. Huang
    International Journal of Molecular Sciences.2026; 27(10): 4186.     CrossRef
  • Methylcobalamin alleviates obesity through gut microbiota remodeling and modulation of bile acid-associated NF-κB signaling in mice
    Xuechun Zhang, Tong Wang, Han Li, Rongrong Ma, Xiaohua Pan, Chang Liu, Yaoqi Tian
    Food Bioscience.2026; 81: 109165.     CrossRef
  • Emerging insights into PPARα′s role in lean metabolic dysfunction-associated steatotic liver disease: Implications for targeted therapies
    Yafei Yang, Furong Zhang, Zhuang Peng, Yafei Wu, Ling Li, Zixia Shen, Qifa Ye, Jiang Yue, Shufang Na
    Acta Pharmaceutica Sinica B.2026;[Epub]     CrossRef
  • Targeting amino acid metabolism in hepatocellular carcinoma
    Yibing Wu, Carmen Chak-Lui Wong
    Trends in Molecular Medicine.2026;[Epub]     CrossRef
  • Unraveling the adverse outcome pathways of metabolic dysfunction-associated steatotic liver disease triggered by environmental mixtures via biological knowledge-driven machine learning
    Jiaming Fu, Guojie Qiao, Kerong Ma, Jinhao Jia, Honghui Li, Zeyang Bai, Limeng Xiong, Yuhan Zhang, Xiaozhe Geng, Hongju Duan, Yuxi Wang, Chunqing Gao, Xiaoyu Li, Yi Zhao, Hao Hu, Guangjun Wang, Rui Zhang, Yihong Di, Huifang Yang, Jian Sun
    Journal of Hazardous Materials.2026; 514: 142869.     CrossRef
  • Metainflammation, Mitochondrial Dysfunction, and Organokine Crosstalk: A Central Axis Linking Metabolic Syndrome to Cardiovascular Diseases
    Ana Flávia Pontes Sodré, Lucca Gonsales Rodrigues, Kátia P. Sloan, Lance A. Sloan, Masaru Tanaka, Rui Curi, Larissa Naomi Takeda, Ricardo de Alvares Goulart, Ana Luiza Decanini Miranda de Souza, Claudia Rucco Penteado Detregiachi, Antonelly Cassio Alves C
    International Journal of Molecular Sciences.2026; 27(15): 6554.     CrossRef
  • Dysregulation of Plasma Nonessential Amino Acids in Early‐Stage Type 2 Diabetes Mellitus
    Abdullah Abbas Hamzah Al-Rubaye, Walaa Esmail Jasim, Ahmed A. Mohsin, Nidhi Chaudhary
    Journal of Nutrition and Metabolism.2026;[Epub]     CrossRef
  • When the Liver Flares: Inflammatory and Immunometabolic Mechanisms Driving the Transition from MASLD to MASH
    Cristina Vecchio, Anteneh Nigussie Sheferaw, Emmanuel Kivumbi, Ian Stoppa, Deepika Pantham, Foteini Christaki, Alessia Provera, Umberto Dianzani, Salvatore Sutti
    Inflammation.2026;[Epub]     CrossRef
  • Food Nutrients and Bioactive Compounds for Managing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review
    Erdenetsogt Dungubat, Kohei Fujikura, Masahiko Kuroda, Toshio Fukusato, Yoshihisa Takahashi
    Nutrients.2025; 17(13): 2211.     CrossRef
  • Current Data on the Role of Amino Acids in the Management of Obesity in Children and Adolescents
    Diana Zamosteanu, Nina Filip, Laura Mihaela Trandafir, Elena Ţarcă, Mihaela Pertea, Gabriela Bordeianu, Jana Bernic, Anne Marie Heredea, Elena Cojocaru
    International Journal of Molecular Sciences.2025; 26(15): 7129.     CrossRef
  • Protein and Macronutrient Metabolism in Liver Cirrhosis: About Sarcopenia
    Seul Ki Han, Soon Koo Baik, Moon Young Kim
    Nutrients.2025; 17(21): 3346.     CrossRef
  • 13,771 View
  • 333 Download
  • 20 Web of Science
  • Crossref